ACTs represent 45.6% of the product type category and oral therapies account for 70.7% of route of administration demand in 2026. The malaria treatment market was valued at USD 1.9 billion in 2025, is projected to reach USD 3.3 billion by 2036 and is forecast to post a 5.1% CAGR between 2026 and 2036.